

Wockhardt Bionova Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Wockhardt Bionova
Wockhardt Bionova Limited (WBL) is a Public Limited Indian Non-Government Company incorporated in India on 02 July 2021 (Three years and ten months 1 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Habil Khorakiwala, Murtaza Khorakiwala, and Zahabiya Khorakiwala serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299MH2021PLC363201
- Company No.
363201
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2021
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Wockhardt Bionova?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Murtaza Khorakiwala ![]() | Director | 02-Jul-2021 | Current |
Habil Khorakiwala ![]() | Director | 02-Jul-2021 | Current |
Zahabiya Khorakiwala ![]() | Director | 02-Jul-2021 | Current |
Financial Performance of Wockhardt Bionova.
Wockhardt Bionova Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Wockhardt Bionova?
Unlock access to Wockhardt Bionova's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Related Corporates (Common Directorship)
- Wockhardt Hospitals Limited
Habil Khorakiwala, Murtaza Khorakiwala and 1 more are mutual person
- Wockhardt Limited
Habil Khorakiwala, Murtaza Khorakiwala and 1 more are mutual person
- Wockhardt Regenerative Private Limited
Zahabiya Khorakiwala is a mutual person
- Rpg Life Sciences Limited
Zahabiya Khorakiwala is a mutual person
- Lysithea Trading & Services Llp
Habil Khorakiwala and Murtaza Khorakiwala are mutual person
- Amalthea Trading & Services Llp
Habil Khorakiwala is a mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Wockhardt Bionova?
Wockhardt Bionova has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Wockhardt Bionova, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt Bionova's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Wockhardt Bionova
Recent activity within the organization
- Annual General Meeting
Wockhardt Bionova Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
- Balance Sheet
Wockhardt Bionova Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Habil Fakhruddin Khorakiwala was appointed as a Director was appointed as a Director on 02 Jul 2021 & has been associated with this company since 3 years 10 months .
- Director Appointment
Murtaza Habil Khorakiwala was appointed as a Director was appointed as a Director on 02 Jul 2021 & has been associated with this company since 3 years 10 months .
- Director Appointment
Zahabiya Habil Khorakiwala was appointed as a Director was appointed as a Director on 02 Jul 2021 & has been associated with this company since 3 years 10 months .
- Company Incorporation
Wockhardt Bionova Limited was registered on 02 Jul 2021 with Roc Mumbai & aged 3 years 10 months as per MCA records.
Recent News, Updates & Announcement
- Wockhardt Q1 net loss narrows to Rs 45 crore.
The company had posted a net loss of Rs 89.18 crore in the same period a year ago. .
- New antibiotic drugs under development to have positive impact in future: Wockhardt's Khorakiwala.
"I believe that the development work on these drugs today will shape the global war on Antimicrobial Resistance (AMR) tomorrow," he added..
- Buyout giants in talks with Wockhardt for domestic formulations business.
The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore..
- Wockhardt's Aurangabad Bioequivalence Centre Receives Zero Observations from USFDA, Boosting Chances for New Drug Approvals.
Wockhardt's bioequivalence centre in Aurangabad, Maharashtra received zero observations from the USFDA after an inspection. This means they followed all the rules and will likely get approvals for their new drugs. #Winning #USFDA #ZeroObservations #Bioequivalence #Wockhardt.
Frequently asked questions
What is the Incorporation or founding date of Wockhardt Bionova Limited?
Wockhardt Bionova Limited was incorporated on 02 Jul 2021.
What is authorized share capital and paid-up capital of Wockhardt Bionova Limited?
The authorized share capital of Wockhardt Bionova Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Wockhardt Bionova Limited?
Currently 3 directors are associated with Wockhardt Bionova Limited.
- Habil Fakhruddin Khorakiwala
- Murtaza Habil Khorakiwala
- Zahabiya Habil Khorakiwala
What is the registered address of Wockhardt Bionova Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Wockhardt Bionova Limited is A/501 5Th Floor Kanakia Zillion Next To Kurla Bus Depot, India, Mumbai, Maharashtra, 400070.
What is the corporate identification number (CIN) and company number of Wockhardt Bionova Limited?
The corporate identification number (CIN) of Wockhardt Bionova Limited is U24299MH2021PLC363201 and the company number is 363201 as per Ministry of Corporate Affairs (MCA).
What is the official website of Wockhardt Bionova Limited?
The Official website of Wockhardt Bionova Limited is https://www.wockhardt.com
When was the last Balance Sheet of Wockhardt Bionova Limited filed with the ROC?
The most recent Balance Sheet for Wockhardt Bionova Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records